A new combination of DNA, metal, and light could revolutionize drug discovery

A new method is cheaper and more environmentally friendly than traditional processes

Teresa Ambrosio


University of Nottingham

The pharmaceutical industry selects new drug candidates by screening a vast number of compounds, called libraries, and testing how they react to biological structures such as antibodies or proteins. Scientists tag compounds with interesting effects by attaching a unique sequence of DNA to them. In a way,  the segment of DNA works like a bar code for the identification of a single molecule in the myriad of molecules that belong to a library.

But creating vast libraries of the compounds with DNA fragments is not an easy task. That's because traditional organic chemistry isn’t suitable for modification of biological compounds. To make reactions, for example, chemists usually use organic solvents such as ether, dichloromethane, or ethyl acetate. But biological molecules, such as DNA, can't be handled with such solvents because they denature.

Teresa Ambrosio

DNA molecules are also very complex entities from a chemistry perspective. They are made of sugars, nucleotides (the part that makes up your unique genetic code), and a chain made of phosphorous to hold them all together. They are quite complicated molecules. Aside from the difficulty of mimicking DNA's living conditions, traditional organic chemistry also doesn’t work well for these types of molecules because it’s difficult to target a single piece in a pool of thousands or millions of different pieces. But scientists at the University of Pennsylvania may have found a solution, making very specific changes to pieces of DNA much easier: the nickel/light procedure.

The nickel/light method helps scientists add molecules to DNA. It starts with a molecule called a photocatalyst, which activates when it is exposed to light. The  activated photocatalyst causes nickel and the molecule that has to be installed into the DNA (like a group of carbon molecules) to react with each other. The molecule, now attached to nickel, can now be transferred to the DNA. This allows chemists to make all sorts of modified DNA molecules. Interestingly, when the chemical bond with the DNA fragment is created, the nickel and the photocatalyst can be reused to form more bonds once the reaction with DNA is finished. 

Teresa Ambrosio

Chemist Gary Molander and his colleagues had previously used this technique for making very specific changes to non-biological molecules in mild conditions, such as room pressure and temperature. However, the procedure had previously never been tested on biological molecules such as DNA. So the University of Pennsylvania team of scientists tested if it was possible to achieve the same reactivity on biomolecules by using the nickel/light protocol. They published this work in the Journal of the American Chemical Society early this year. 

This nickel/light procedure might sound like an exotic, or almost magic, concept. In fact, it is quite the opposite, as the set up is ridiculously simple. You just need to put all the components — a short fragment of DNA, the nickel, the light-absorbing photocatalyst and the molecule to attach to the DNA — in a tube, shake it for as little as 10 minutes, shine light onto it, and the magic is done. By using this procedure, it was possible to selectively introduce up to 50 different molecules to the final part of this short fragment of DNA without damaging any other region of the fragment.

In this study, only one fragment of DNA was chosen to develop and test this new procedure, but potentially any short fragment of DNA can undergo this transformation. This versatility, combined with the ease of this DNA modification, are very desirable features for pharmaceutical industries. In fact, this method can be applied to create new DNA-encoded libraries which play an important role in the discovery of new drugs.

This method stands out for its affordability and sustainability, potentially reducing the cost of current and new drugs on the market. In fact, compared to existing procedures that allow for the modification of DNA, this nickel/light method has a wide range of advantages. First, from a sustainability point of view the reaction is quite green. It uses light instead of heat as a form of energy. Additionally, the reaction occurs at room temperature, at the same pressure as the open air, so there is no need to heat up the tube or use expensive, high pressure gases such as pure nitrogen or argon. All these aspects taken together reduce costs dramatically and the environmental impact of this procedure is far better than the previous techniques.

The answer to many of the world's unsolved scientific questions may be rethinking the way we do science. We can't achieve progress if we still rely on the chemistry discovered 200 years ago. We need disruptive ideas to overcome challenges and bridge gaps in current scientific knowledge.

Comment Peer Commentary

We ask other scientists from our Consortium to respond to articles with commentary from their expert perspective.

Xinwen Zhu

Systems Biology

Boston University

Thanks for the article, this is a really cool technology! I’ve heard of DNA barcoding a lot in the context of tagging nucleic acids for things like single-cell sequencing, but I hadn’t appreciated its potential in drug discovery. Barcoding could be very useful in preliminary experiments looking for small molecules that bind proteins of interest (say, if a protein is responsible for a disease and we just need a drug to stick to it) - one could throw the entire library into the assay and then figure out which molecules stay bound to the target proteins by DNA sequencing. I wonder though whether this is helpful for phenotypic screening, where libraries of small molecules are thrown onto cells or organoids and the readout is the biological response. I imagine that a bulky DNA molecule would get in the way, and it’s also not feasible to test more than one molecule at a time if we are measuring cellular responses (one compound per well of a 1536 well plate…). But wow, the chemistry of this is super neat, and I expect people will come up with all sorts of reasons to stick DNA to other molecules that I can’t even imagine!

Lauren Gandy

Biochemistry, Microbiology, and Chemical Biology

Rensselaer Polytechnic Institute

Great article Teresa and so relevant! I know especially for the big neurodegenerative diseases, like Alzheimer’s and Parkinson’s, there is great interest in DELs. But the difficulties, like you point out, remain the feasibility of synthetic construction; whether to use click chemistry or other reactions like the Negishi on these large biomolecules. It’s amazing that the group made a one-pot reaction without the harsh conditions normally required for this type of reaction using a highly accessible (and not super expensive) photocatalyst. Hopefully they can partner with a company to share their knowledge and start creating these compounds for the medical field!

Fiona Scott

Chemistry and Chemical Cancer Biology

University of Sussex

Nice article @Teresa! You give a good overview of the chemical structure of DNA and how its chemical stability doesn’t survive in the typical reactions we run in the lab. You also describe the catalytic process really well in words. Would it be possible to include a simplified figure of the catalytic cycle in the future?

DNA encoded libraries are making it much easier to fish out useful compounds from screens when looking for potential drug targets - I’ve heard a fair few talks about the benefits of DNA-coded libraries being introduced over the years.

Photochemistry is a really popular field at the moment and it’s good to see it being applied to drug discovery here. My only concern with this method is that it still involves the use of metals. In late-stage drug synthesis, it is good to avoid conditions involving metals because of trace quantities of e.g. nickel here, can interfere with the biochemical assay. It’s a step in the right direction though as we seek to carry out chemical reactions in a greener manner. Maybe eventually they’ll develop a photocatalyst that doesn’t contain a metal?